Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):28-36. doi: 10.1016/j.drugalcdep.2008.06.016. Epub 2008 Sep 20.

2.

Network therapy: decreased secondary opioid use during buprenorphine maintenance.

Galanter M, Dermatis H, Glickman L, Maslansky R, Sellers MB, Neumann E, Rahman-Dujarric C.

J Subst Abuse Treat. 2004 Jun;26(4):313-8.

PMID:
15182896
3.

Coronary artery disease and opioid use.

Marmor M, Penn A, Widmer K, Levin RI, Maslansky R.

Am J Cardiol. 2004 May 15;93(10):1295-7.

PMID:
15135709
4.

A prisoner with acute renal failure.

Maslansky R.

Lancet. 2004 May 1;363(9419):1474. No abstract available.

PMID:
15121415
5.

Short-term buprenorphine maintenance: treatment outcome.

Galanter M, Dermatis H, Resnick R, Maslansky R, Neumann E.

J Addict Dis. 2003;22(3):39-49.

PMID:
14621343
6.

Metaphors, misuse, and misconceptions.

Maslansky R.

Science. 2003 Sep 12;301(5639):1479-82; author reply 1479-82. No abstract available.

PMID:
12970545
7.

Tuberculosis knowledge among New York City injection drug users.

Wolfe H, Marmor M, Maslansky R, Nichols S, Simberkoff M, Des Jarlais D, Moss A.

Am J Public Health. 1995 Jul;85(7):985-8.

8.

The impact on behavior of notifying methadone patients of their HIV serostatus.

Katz SM, Galanter M, Lifshutz H, Maslansky R.

Am J Drug Alcohol Abuse. 1995 Feb;21(1):37-45.

PMID:
7762543
9.

Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.

Marmor M, Titus S, Wolfe H, Krasinski K, Maslansky R, Simberkoff M, Beatrice S, Nichols S, Des Jarlais DC.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S207-13.

PMID:
7865302
10.

Doctors and police custody.

Maslansky R.

Lancet. 1993 Jun 26;341(8861):1657. No abstract available.

PMID:
8100011
11.

Implications of the revised surveillance definition: AIDS among New York City drug users.

Des Jarlais DC, Wenston J, Friedman SR, Sotheran JL, Maslansky R, Marmor M, Yancovitz S, Beatrice S.

Am J Public Health. 1992 Nov;82(11):1531-3.

12.

Stroke.

Maslansky R.

Lancet. 1992 Mar 21;339(8795):750. No abstract available.

PMID:
1347623
13.

Crack cocaine use in a cohort of methadone maintenance patients.

Des Jarlais DC, Wenston J, Friedman SR, Sotheran JL, Maslansky R, Marmor M.

J Subst Abuse Treat. 1992 Fall;9(4):319-25.

PMID:
1479629
14.

Treatment retention of patients referred by public assistance to an alcoholism clinic.

Brizer DA, Maslansky R, Galanter M.

Am J Drug Alcohol Abuse. 1990;16(3-4):259-64.

PMID:
2288324
15.

HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Des Jarlais DC, Friedman SR, Novick DM, Sotheran JL, Thomas P, Yancovitz SR, Mildvan D, Weber J, Kreek MJ, Maslansky R.

JAMA. 1989 Feb 17;261(7):1008-12.

PMID:
2915408
16.

A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.

Stoneburner RL, Des Jarlais DC, Benezra D, Gorelkin L, Sotheran JL, Friedman SR, Schultz S, Marmor M, Mildvan D, Maslansky R.

Science. 1988 Nov 11;242(4880):916-9.

PMID:
3187532
17.

The AIDS epidemic among blacks and Hispanics.

Friedman SR, Sotheran JL, Abdul-Quader A, Primm BJ, Des Jarlais DC, Kleinman P, Maugé C, Goldsmith DS, el-Sadr W, Maslansky R.

Milbank Q. 1987;65 Suppl 2:455-99.

PMID:
3451064
18.

A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.

Adler L, Angrist B, Peselow E, Corwin J, Maslansky R, Rotrosen J.

Br J Psychiatry. 1986 Jul;149:42-5.

PMID:
2877708
19.

AIDS and the intravenous drug abuser.

Brambill K, Maslansky R.

J Subst Abuse Treat. 1986;3(3):155. No abstract available.

PMID:
3806727
20.

Letter: Methadone maintenance.

Maslansky RA.

JAMA. 1976 Sep 27;236(13):1452. No abstract available.

PMID:
989108
21.

Forum: preventive dentistry.

Maslansky RA.

Prev Med. 1976 Sep;5(3):328-46. No abstract available.

PMID:
967830
22.

Editorial: Emergency room experience with chemical abuse.

Maslansky R.

Minn Med. 1974 Feb;57(2):108-9. No abstract available.

PMID:
4813607
23.

Letter: Methadone maintenance.

Maslansky RA.

JAMA. 1974 Jan 14;227(2):201. No abstract available.

PMID:
4859608
24.

Effect of methadone on human pregnancy tests.

Horwitz CA, Maslansky R, Waldinger R, Cabrera H, Ward PC.

J Reprod Fertil. 1973 Jun;33(3):489-93. No abstract available.

25.

Treatment of chemical dependency of the morphine type.

Maslansky RA.

Minn Med. 1973 Mar;56(3):205-6. No abstract available.

PMID:
4688364
26.

Opiate addiction 1971.

Maslansky R.

Minn Med. 1971 Jul;5(7):553-5. No abstract available.

PMID:
5105696
27.

Methadone maintenance programs in Minneapolis.

Maslansky R.

Int J Addict. 1970 Sep;5(3):391-405. No abstract available.

PMID:
5524376
28.

SUSPECTED MYOCARDIAL INFARCTION.

MASLANSKY RA, WOOLFREY BF.

Minn Med. 1964 Jul;47:829-35. No abstract available.

PMID:
14243324
29.

Traumatic interventricular septal defect.

COE JI, MASLANSKY RA, WOODSON RD.

Minn Med. 1959 Dec;42:1798-801. No abstract available.

PMID:
13810851

Supplemental Content

Loading ...
Support Center